Cargando…
Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay
Polo-like kinase 1 (Plk1) plays several roles in cell division and it is a recognized cancer drug target. Plk1 levels are elevated in cancer and several types of cancer cells are hypersensitive to Plk1 inhibition. Small molecule inhibitors of the kinase domain (KD) of Plk1 have been developed. Their...
Autores principales: | Normandin, Karine, Lavallée, Jean-François, Futter, Marie, Beautrait, Alexandre, Duchaine, Jean, Guiral, Sébastien, Marinier, Anne, Archambault, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118709/ https://www.ncbi.nlm.nih.gov/pubmed/27874094 http://dx.doi.org/10.1038/srep37581 |
Ejemplares similares
-
Coupling of Polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry
por: Kachaner, David, et al.
Publicado: (2017) -
Interdomain allosteric regulation of Polo kinase by Aurora B and Map205 is required for cytokinesis
por: Kachaner, David, et al.
Publicado: (2014) -
Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain
por: Chen, Yunyu, et al.
Publicado: (2016) -
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key
por: Pintard, Lionel, et al.
Publicado: (2018) -
A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018)